Match!
Harm Reduction Journal
IF
2.75
Papers
633
Papers 633
1 page of 64 pages (633 results)
Newest
#1Ellen Childs (BU: Boston University)H-Index: 3
#2Sabrina A. Assoumou (BU: Boston University)H-Index: 6
Last.Angela R. Bazzi (BU: Boston University)H-Index: 7
view all 9 authors...
Background Hepatitis C virus (HCV) infection is increasingly prevalent among people who inject drugs (PWID) in the context of the current US opioid crisis. Although curative therapy is available and recommended as a public health strategy, few PWID have been treated. We explore PWID narratives that explain why they have not sought HCV treatment or decided against starting it. We then compare these narratives to evidence-based and guideline-concordant information to better enable health, social s...
#1Anna P. Deryabina (Columbia University)H-Index: 4
#2Padmaja Patnaik (Columbia University)H-Index: 1
Last.W. El Sadr (Columbia University)H-Index: 62
view all 3 authors...
We conducted a cross-sectional integrated bio-behavioral survey among sex partners of persons who inject drugs (PWID) to explore reasons for reported increase in reporting of heterosexually transmitted HIV in Kazakhstan and Kyrgyzstan. Sexual partners of PWID were recruited through PWID. Behavioral data were collected through semi-structured interviews. Dried blood spots were obtained and tested for HIV and hepatitis C virus antibodies (HCVAb). Descriptive univariate and bivariate analyses, and ...
#1Andrew ScheibeH-Index: 8
#2Katherine YoungH-Index: 3
Last.Harry HauslerH-Index: 9
view all 12 authors...
People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis services exist for PWID. We assessed HCV, HBV and HIV prevalence and risk factors among PWID accessing harm reduction services in Cape Town, Durban and Pretoria to inform policy and programming. We conducted a cros...
#1Don C. Des Jarlais (NYU: New York University)H-Index: 90
#2Courtney McKnight (NYU: New York University)H-Index: 18
Last.Hannah L. F. Cooper (Emory University)H-Index: 32
view all 6 authors...
To identify geographic “hotspots” for potential transmission of HIV and HCV and for drug overdose among persons who use heroin and cocaine in New York City and to examine historical continuities in problem drug use hotspots in the city. A total of 2714 study participants were recruited among persons entering Beth Israel substance use treatment programs. A structured questionnaire was administered and blood samples for HIV and HCV testing were collected. Hotspots for potential virus transmission ...
#1Mojca Matičič (University of Ljubljana)H-Index: 14
Last.Jeffrey V. Lazarus (University of Barcelona)H-Index: 25
view all 5 authors...
Hepatitis C virus (HCV) infection is the leading cause of cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC) worldwide. In Europe, people who inject drugs (PWID) represent the majority of HCV infections, but are often excluded from treatment. The aim of this study was to report on national HCV strategies, action plans and guidelines in European countries that include HCV treatment for the general population as well as for PWID. Data on access to direct-acting antivirals (DAAs)...
#1Siddharth Iyengar (UM: University of Miami)H-Index: 1
#2Adam Kravietz (UM: University of Miami)H-Index: 1
Last.Hansel Tookes (UM: University of Miami)H-Index: 1
view all 5 authors...
In March of 2016, Florida passed the Infection Disease Elimination Act (IDEA), legalizing the formation of the first syringe exchange program in Florida, which opened in December of 2016 at a fixed site in Overtown, Miami. Since that time, the exchange expanded in April of 2017 to include a mobile van unit that provides the same services at different locations throughout Miami-Dade County. Trained interviewers conducted face-to-face interviews from all first-time participants at the IDEA Exchang...
#1Joanne Neale ('KCL': King's College London)H-Index: 27
#2Charlotte N. E. Tompkins ('KCL': King's College London)H-Index: 12
Last.John Strang ('KCL': King's College London)H-Index: 62
view all 3 authors...
Background Options for opioid agonist therapy (OAT) are expanding with the development of prolonged-release (also known as extended-release) 1-week, 1-month, and 6-month formulations of buprenorphine. There is an assumption that patients will welcome these new treatments and medication adherence will correspondingly increase. However, there has been little research exploring patients’ views of prolonged-release buprenorphine. This paper aims to understand which durations patients prefer and why,...
#1IslamSalequl (JU: Jahangirnagar University)H-Index: 7
#2Damani Arnold Piggott (Johns Hopkins University)H-Index: 7
Last.Gregory D Kirk (Johns Hopkins University)H-Index: 48
view all 7 authors...
Background Bacterial infection is a major cause of morbidity and mortality for persons who inject drugs (PWID). Injection cessation may help abrogate such infections, but maintaining complete cessation is challenging. Limited data exists on the role of reduced injection intensity on invasive bacterial infection risk. We sought to evaluate decreased risk for bacterial infections following cessation and substantive reduction in the injection intensity.
#1Candice Luo (McMaster University)H-Index: 3
#2Nitika Sanger (McMaster University)H-Index: 4
Last.Zainab SamaanH-Index: 18
view all 11 authors...
Ever-increasing numbers of opioid use disorder (OUD) in Canada has created the recent opioid crisis. One common treatment for OUD is methadone maintenance treatment (MMT). Various factors, including being a parent which entails specific stressors, may increase susceptibility to negative treatment outcomes. This study aims to investigate differences between OUD patients with and without children in socio-demographic and clinical outcomes. Data for this study are part of a larger program. All part...
#1Phung Quoc Tat Than (Duy Tan University)
#2Bach Xuan Tran (Johns Hopkins University)H-Index: 45
Last.Roger C. M. Ho (NUS: National University of Singapore)H-Index: 33
view all 8 authors...
Despite existing efforts to provide antiretroviral treatment (ART) for all HIV-diagnosed people, stigma deprives them of the highest attainable health status and challenges the effectiveness of ART program in Vietnam. This study aimed to assess five dimensions of HIV-related stigma and explore its associated factors among ART patients in a multisite survey. Implications of this study support the development of HIV policies to improve patients’ access, utilization, and outcomes of ART program tow...
12345678910